全文获取类型
收费全文 | 85885篇 |
免费 | 9080篇 |
国内免费 | 3037篇 |
专业分类
耳鼻咽喉 | 451篇 |
儿科学 | 1948篇 |
妇产科学 | 618篇 |
基础医学 | 7012篇 |
口腔科学 | 1613篇 |
临床医学 | 9002篇 |
内科学 | 13675篇 |
皮肤病学 | 1260篇 |
神经病学 | 1809篇 |
特种医学 | 3783篇 |
外国民族医学 | 96篇 |
外科学 | 6414篇 |
综合类 | 16319篇 |
现状与发展 | 20篇 |
一般理论 | 4篇 |
预防医学 | 7175篇 |
眼科学 | 940篇 |
药学 | 6963篇 |
58篇 | |
中国医学 | 4163篇 |
肿瘤学 | 14679篇 |
出版年
2024年 | 228篇 |
2023年 | 1637篇 |
2022年 | 2668篇 |
2021年 | 4496篇 |
2020年 | 4097篇 |
2019年 | 3212篇 |
2018年 | 3032篇 |
2017年 | 3384篇 |
2016年 | 3822篇 |
2015年 | 3733篇 |
2014年 | 6015篇 |
2013年 | 6117篇 |
2012年 | 5465篇 |
2011年 | 5838篇 |
2010年 | 4649篇 |
2009年 | 4344篇 |
2008年 | 4204篇 |
2007年 | 4464篇 |
2006年 | 3866篇 |
2005年 | 3507篇 |
2004年 | 2770篇 |
2003年 | 2344篇 |
2002年 | 1915篇 |
2001年 | 1795篇 |
2000年 | 1432篇 |
1999年 | 1077篇 |
1998年 | 997篇 |
1997年 | 915篇 |
1996年 | 717篇 |
1995年 | 679篇 |
1994年 | 623篇 |
1993年 | 446篇 |
1992年 | 501篇 |
1991年 | 426篇 |
1990年 | 361篇 |
1989年 | 327篇 |
1988年 | 316篇 |
1987年 | 281篇 |
1986年 | 236篇 |
1985年 | 192篇 |
1984年 | 157篇 |
1983年 | 109篇 |
1982年 | 111篇 |
1981年 | 84篇 |
1980年 | 89篇 |
1979年 | 81篇 |
1978年 | 50篇 |
1977年 | 50篇 |
1976年 | 38篇 |
1975年 | 38篇 |
排序方式: 共有10000条查询结果,搜索用时 24 毫秒
31.
Ignasi Esteban Carmen Pastor-Quiones Lorena Usero Montserrat Plana Felipe García Lorna Leal 《Viruses》2021,13(3)
Over 36 million people worldwide are infected with HIV. Antiretroviral therapy (ART) has proven to be highly effective to prevent HIV-1 transmission, clinical progression and death. Despite this success, the number of HIV-1 infected individuals continues increasing and ART should be taken for life. Therefore, there are two main priorities: the development of preventive vaccines to protect from HIV acquisition and achieve an efficient control of HIV infection in the absence of ART (functional cure). In this sense, in the last few years, there has been a broad interest in new and innovative approaches such as mRNA-based vaccines. RNA-based immunogens represent a promising alternative to conventional vaccines because of their high potency, capacity for rapid development and potential for low-cost manufacture and safe administration. Some mRNA-based vaccines platforms against infectious diseases have demonstrated encouraging results in animal models and humans. However, their application is still limited because the instability and inefficient in vivo delivery of mRNA. Immunogens, design, immunogenicity, chemical modifications on the molecule or the vaccine delivery methods are all crucial interventions for improvement. In this review we, will present the current knowledge and challenges in this research field. mRNA vaccines hold great promises as part of a combined strategy, for achieving HIV functional cure. 相似文献
32.
Francisca Morgado Mariana Batista Ana Moreno Inês Coutinho 《Pediatric dermatology》2021,38(1):191-193
We present a 6‐year‐old girl with skin hyperpigmentation, leukoplakia, and onychodystrophy, the classic mucocutaneous triad usually associated with dyskeratosis congenita. The patient also had premature graying of the hair, bone marrow failure, hepatitis, exudative retinopathy, osteopenia with multiple long bone fractures, and intracranial calcifications and brain cysts. Coats plus syndrome is a rare disease with a clinical and genetic overlap with dyskeratosis congenita. This disease is reviewed, with a focus on the pathogenesis of the genetic anomalies and its background as a telomere biology disorder. 相似文献
33.
《药学学报(英文版)》2020,10(3):414-433
The T cell co-stimulatory molecule OX40 and its cognate ligand OX40L have attracted broad research interest as a therapeutic target in T cell-mediated diseases. Accumulating preclinical evidence highlights the therapeutic efficacy of both agonist and blockade of the OX40–OX40L interaction. Despite this progress, many questions about the immuno-modulator roles of OX40 on T cell function remain unanswered. In this review we summarize the impact of the OX40–OX40L interaction on T cell subsets, including Th1, Th2, Th9, Th17, Th22, Treg, Tfh, and CD8+ T cells, to gain a comprehensive understanding of anti-OX40 mAb-based therapies. The potential therapeutic application of the OX40–OX40L interaction in autoimmunity diseases and cancer immunotherapy are further discussed; OX40–OX40L blockade may ameliorate autoantigen-specific T cell responses and reduce immune activity in autoimmunity diseases. We also explore the rationale of targeting OX40–OX40L interactions in cancer immunotherapy. Ligation of OX40 with targeted agonist anti-OX40 mAbs conveys activating signals to T cells. When combined with other therapeutic treatments, such as anti-PD-1 or anti-CTLA-4 blockade, cytokines, chemotherapy, or radiotherapy, the anti-tumor activity of agonist anti-OX40 treatment will be further enhanced. These data collectively suggest great potential for OX40-mediated therapies. 相似文献
34.
35.
36.
目的:探讨单孔胸腔镜下肺癌手术术后胸腔引流时间的影响因素。方法:本研究采用回顾性分析方法,回顾我院2018年01月至2019年12月原发性肺癌患者经单孔胸腔镜手术治疗的病例199例。按照术后胸腔引流时间分为两组,Ⅰ组(术后胸腔引流时间<5天)和Ⅱ组(术后胸腔引流时间≥5天)。对于影响术后胸腔引流时间的可能因素在两组间先采用单因素分析的方法筛选,再将筛选出来的对术后胸腔引流时间可能有意义的影响因素进行二项Logistic多因素回归分析。结果:经单因素分析及二项Logistic多因素回归分析结果显示:年龄≥60岁、手术部位、肺段切除术、胸膜粘连、手术时间≥180 min、术后早期下床活动是术后胸腔引流时间的独立影响因素(P<0.05)。结论:对于具有多个延长术后胸腔引流时间的独立影响因素的患者,应制定个体化管理方案,尽可能减少术后胸腔引流时间,减少住院天数,加快患者康复。 相似文献
38.
39.
笔者根据现代临床子宫内膜的病理演变过程结合中医“异病同治”理念,提出“子宫内膜功能亢进性疾病”概念,涵盖5种常见的子宫内膜疾病:无排卵性异常子宫出血(Abnormal Uterine Bleeding Ovulatory dysfunction,AUB-O),子宫内膜息肉(Endometrial Polyp,EP),子宫内膜异位症(Endometriosis,EMs),子宫腺肌病(Adenomyosis,AM),子宫内膜癌(Endometrial Carcinoma,EC)。基于文献的汇总,分析得到此类疾病的子宫内膜病理演变与中医病因病机的关联性,为寻找关键通路、创新性治疗此类疾病提供了重要的参考方向,对深化中医妇科学常见疾病的共性病因病机提供了理论依据和探索思路。 相似文献
40.
Tsvetelina Velikova 《World Journal of Immunology》2022,12(2):9-14
To control the pandemic, efficient vaccines must be applied to the population, including patients with autoimmune diseases. Therefore, one can expect that coronavirus disease 2019 (COVID-19) vaccines may influence the underlying autoimmune processes in these patients. Additionally, it is essential to understand whether COVID-19 vaccines would be effective, safe, and provide long-lasting immunological protection and memory. However, the currently available and approved COVID-19 vaccines turned out to be safe, effective, and reliable in patients with autoimmune inflammatory and rheumatic diseases. Furthermore, most patients said they felt safer after getting vaccinations for COVID-19 and reported enhanced overall quality of life and psychological wellbeing. In general, the COVID-19 vaccines have been highly tolerated by autoimmune patients. Such findings might comfort patients who are reluctant to use COVID-19 vaccines and assist doctors in guiding their patients into receiving vaccinations more easily and quickly. 相似文献